Add to My Stocks
$4.09 $0.14 (3.54%) PCSA stock closing price Sep 20, 2018 (Closing)
Prev Close* : $3.95
Market Cap:
Day Low: $4
52 Week Low: $1.85
Open: $4
Volume: -
Day High: $4.22
52 Week High: $5.13

Latest Stock Market News

Latest Articles

PCSA Stockcharts

View PCSA PE ratio, PS ratio stocks charts and compare with peers.
PCSA Chart
Note: Compare PROCESSA PHARMA stock price history with the index and industry peers.


PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio


(return on equity)

PROCESSA PHARMA Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

PCSA Industry Peers

Company Price Change (%)
Cti Biopharma (CTIC)2.010.1 (5.24%)
Oasmia Pharma (OASM)2.560.19 (6.91%)
Vernalis (VNLPY)0.380 (0%)
Champions Oncology (CSBR)13.210.77 (5.51%)
Gencor Industries (GENC)12.70.25 (2.01%)
Astec Industries (ASTE)52.491.21 (2.36%)
Manitowoc (MTW)26.371.87 (7.63%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Galectin Therapeutics (GALT)6.930.88 (14.55%)
Lannett Co (LCI)5.50.65 (13.4%)
TherapeuticsMD (TXMD)6.750.53 (8.52%)
Akebia Therapeutics (AKBA)8.330.59 (7.62%)
ArQule (ARQL)5.150.3 (6.19%)
Enanta Pharma (ENTA)97.685.59 (6.07%)
CTI BioPharma (CTIC)2.010.1 (5.24%)
Top gainers from Medical-Drugs industry
* As of Sep 21, 2018
CompanyPriceChange (%)
Rigel Pharma (RIGL)3.320.27 (7.52%)
MOLECULAR TEMPL (MTEM)5.790.46 (7.36%)
Achaogen (AKAO)4.310.25 (5.48%)
Flexion Therapeutics (FLXN)18.870.75 (3.82%)
CORREVIO PHARMA (CORV)4.290.1 (2.28%)
Heron Therapeutics (HRTX)33.10.6 (1.78%)
Portola Pharma (PTLA)28.170.46 (1.61%)
Top losers from Medical-Drugs industry
* As of Sep 21, 2018

PROCESSA PHARMA Financial Statements

income statement2017201620152014
Net Sales or Revenues----
Net Income-1.85M-0.33M-3.35M-4.52M
Total Operating Expense0002.84M
View PROCESSA PHARMA income statement
balance sheet2017201620152014
Total Assets2.98M--2.54M
Total Liabilities2.6M2.35M2.08M1.33M
Shareholders Equity--2.35M-1.97M1.2M
View PROCESSA PHARMA balance sheet
cash flow statement2017201620152014
Net Increase (Decrease) in Assets Liabilities----0.25M
Net Cash from (used by) Operating Activities-1.65M-0.04M-0.87M-2.69M
Increase (Decrease) in Prop Plant And Equipment-0.02M---0.01M
View PROCESSA PHARMA cash flow statement

PROCESSA PHARMA Stock Message Board

PROCESSA PHARMA stock price ended the last trading day at $4.09. PROCESSA PHARMA market capitalization is $152.76M and it represents the total market value of PCSA stock. A value investor must look at the fundamentals of a stock, and perform PROCESSA PHARMA valuation, even though in the short-term, sentiment and current breaking news might affect PROCESSA PHARMA stock price.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that PROCESSA PHARMA is worth a lot, it will most likely be reflected in an inflated PROCESSA PHARMA stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 1,050 on the last trading day, as is evident from PROCESSA PHARMA stock chart, and PCSA stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. PROCESSA PHARMA dividend per share was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking PROCESSA PHARMA stock price history.